期刊文献+

万古霉素最低抑菌浓度漂移对甲氧西林耐药金黄色葡萄球菌感染治疗效果的影响 被引量:15

Effect of vancomycin minimum inhibitory concentration creeping on the treatment outcome of MRSA infections
下载PDF
导出
摘要 目的了解万古霉素最低抑菌浓度(MIC)的变化与治疗甲氧西林耐药金葡菌(MRSA)感染之间的关系。方法分析2007—2009年安徽省立医院微生物实验室MRSA的分离率及MRSA万古霉素的MIC值变化,并结合临床资料评价万古霉素MIC漂移对疗效的影响。结果 3年中我院MRSA在金葡菌中的比率逐渐增加。未发现万古霉素耐药株,但MIC≤0.5mg/L的菌株所占比率逐年下降,而MIC≥2.0 mg/L的比率逐年上升。MIC≤1 mg/L时,治愈率、临床有效率、细菌清除率分别为56.5%、87.0%和78.3%,MIC≥2 mg/L时,分别为44.0%、68.0%和64.0%,抗菌药物平均使用时间后者明显延长。结论 3年中我院MRSA在金葡菌中分离率增加,万古霉素MIC显著增高,但治愈率、临床有效率、细菌清除率仍无差异。 Objective The aim of this study was to investigate the clinical relevance of vanconaycin minimum inhibitory concentration (MIC) creeping for treatment outcome of methicillinresistant Staphylococcus aureus (MRSA) infections. Methods Nonduplicate MRSA strains were isolated from clinical samples of patients in Anhui Provincial Hospital from January 2007 to January 2009. The prevalence of MRSA and the trend of vanconaycin MIC for S. aureus isolates were analyzed over 3 years. The clinical relevance of vancomycin minimum inhibitory concentration values creeping for treatment outcome of MRSA infec tions was discussed consdiering the clinical data. Results In the past 3 years, the prevalence of MRSA had kept increasing. In crease of vancomycin MIC was observed even though no vanconayeinresistant S. aureus was identified. In the 3 years, the pro portion of MRSA strains with MIC ≤ 0.5 nag/L decreased, while the percentage of MRSA strains with MIC ≤2.0 nag/L in creased. When vaneomycin MIC 1 nag/L, the cure rate, clinical effecacy rate and bacterial clearance rate were 56. 5%, 87.0% and 78.3%, respectively. When MIC ≥2 mg/L, the corresponding rates were 44.0%, 68.0% and 64.0%, respec tively. The average hospital stay and duration of antibiotic treatment were significantly longer. Conclusions In the 3year period, the prevalence of MRSA was increasing gradually. The MIC value of vanconaycin showed an creeping trend. However, the cure rate, clinical effeeacy rate and bacterial clearance rate in vancomycintreated MRSA infections did not show significant difference.
出处 《中国感染与化疗杂志》 CAS 北大核心 2013年第2期121-123,共3页 Chinese Journal of Infection and Chemotherapy
基金 安徽省自然科学基金(11040606M205)
关键词 甲氧西林耐药金黄色葡萄球菌 万古霉素 最低抑菌浓度 methicillin-resustant Staphylococcus aureus vancomycin minimum inhibitory concentration
  • 相关文献

参考文献8

  • 1Ito T, Okuma X,Ma XX,et al. Insights on antibiotic ofStaphylococcus aureus from its whole genome: genomic is-land SCC[J]. Drug resist Update, 2003,6(1) :41-52.
  • 2汪复,朱德妹,胡付品,阮斐怡,倪语星,孙景勇,徐英春,张小江,胡云健,艾效曼,俞云松,杨青,孙自镛,简翠,贾蓓,黄文祥,卓超,苏丹虹,魏莲花,吴玲,张朝霞,季萍,王传清,薛建昌,张泓,李万华.2008年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2009,9(5):321-329. 被引量:422
  • 3汪复,朱德妹,胡付品,阮斐怡,倪语星,孙景勇,徐英春,张小江,胡云健,艾效曼,俞云松,杨青,孙自镛,李丽,贾蓓,黄文祥,卓超,苏丹虹,魏莲花,吴玲,张朝霞,季萍,王传清,薛建昌,张泓,李万华,徐元宏,沈继录,单斌,杜艳.2009年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2010,10(5):325-334. 被引量:397
  • 4李娜,郭志强.耐甲氧西林金黄色葡萄球菌医院感染分析[J].山东医药,2004,44(7):6-6. 被引量:3
  • 5Wang G, Hindler FJ,Ward WK,et al. Increased vancomycinMICs for Staphylococcus aureus clinical isolates from a uni-versity hospital during a 5-year period[j]. J Clin Microbiol,2006, 44(11): 3883-3886.
  • 6Sakoulas G,Moise-Broder PA, Schentag J, et al. Relation-ship of MIC and bactericidal activity to efficacy of vancomycinfor treatment of methicillin-resistant Staphylococcus aureusbacteremia[J]. J Clin Microbiol, 2004, 42(16) : 2398-2402.
  • 7Moise PA,Sakoulas G,Forrest A,et al. Vancomycin invitro bactericidal activity and its relationship to efficacy inclearance of methicillin-resistant Staphylococcus aureus bac-teremia[J]. J Antimicrob Agents Chemother, 2007, 51(7):2582-2586.
  • 8Maclayton DO, Hall RG 2nd. Pharmacologic treatment op-tions for nosocomial pneumonia involving methicillin-resistantStaphylococcus aureus [J]. Ann Pharmacother, 2007, 41(2): 235-244.

二级参考文献27

  • 1王辉,郭萍,孙宏莉,杨启文,陈民钧,朱元珏,徐英春,谢秀丽.碳青霉烯类耐药的不动杆菌分子流行病学及其泛耐药的分子机制[J].中华检验医学杂志,2006,29(12):1066-1073. 被引量:237
  • 2Clinical and I.aboratory Standards Institute(CLSI). Perform ance standards for Antimicrobial susceptibility testing[S]. M100-S17, 2007.
  • 3Clinical and Laboratory Standards Institute (CLSI). Perform anee standards for Antimicrobial susceptibility testing [S]. M100-S19,2009.
  • 4Bratu S, I.andman D, Haag R, et al. Rapid spread of carbapenem resistant Klebsiella pneumoniae in New York City: anew threat to our antibiotic armamentarium[J]. Arch Int Meal.2005,165(12) :1430-1435.
  • 5Endimiani A, Hujer AM, Perez F, et al. Characterization of blaKPC containing Klebsiella pneumoniae isolates detected in different institutions in the eastern USA [J]. J Antimierob Chemother, 2009, 63(3):427-437.
  • 6Jeon BC, Jeong SH, Bae IK, et al. Investigation of a nosocomial outbreak of imipenem resistant Acinetobacter baumannii producing the OXA- 23 β- lactamase in Korea[J]. J Clin Microbiol, 2005, 43(5):2241 -2245.
  • 7NaasT, LevyM, HirschauerC, et al. Outbreak ofcarbapen em resistant Acinetobacter baumannii producing the carbap enemase OXA- 23 in a tertiary care hospital of Pepcete, French Polynesta[J]. J Clin Mierohiol, 2005, 43 (9) : 4826- 4829.
  • 8Waites KB, Dully LB, Dowzicky MJ. Antimicrobial susceptibility among pathogens collected from hospitalized patients in the United States and invitro activity of tigecycline, a new glycylcycline antimicrobial[J]. Antimicrob Agents Chemother, 2006,50(10):3479- 3484.
  • 9Souli M, Kontopidou FV, Koratzanis E, et al. lnvitro activity of tigecycline against multiple-drug resistant, including pan resistant, Gram negative and Gram-positive clinical isolates from Greek hospitals[J]. Antimicrob Agents Chemother, 2006.50(9) :3166- 3169.
  • 10Gordon NC, Warehan, DW. A review of clinical and microbiological outcomes following treatment of infections involving multidrug-resistant Acinetobacter baumannii with tigecycline [J]. J Antimicrob Chemother, 2009, 63(4) :775-780.

共引文献755

同被引文献97

引证文献15

二级引证文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部